Jardiance 10 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FXUZ2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,790
Award facts
- Contract value 100% obligated
- $13,789.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of Jardiance 10 mg tablets in a quantity of 90 units, with a contract ceiling value of $13,789.80. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters, with an ultimate completion date of January 23, 2026. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems.
This delivery order represents a routine pharmaceutical supply transaction supporting military healthcare programs. Jardiance is a diabetes medication used in treatment regimens for military personnel and veterans. The underlying IDC vehicle demonstrates AmerisourceBergen's established capability to supply a comprehensive range of pharmaceutical products, medical supplies, and specialty medications across multiple therapeutic domains to the Department of Defense and related federal healthcare systems. The competitive award reflects the company's competitive positioning within the federal pharmaceutical distribution market for the Defense Logistics Agency's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26FXUZ2?
SPE2DR26FXUZ2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FXUZ2 worth?
The government has obligated $13,790 on SPE2DR26FXUZ2.
Is contract SPE2DR26FXUZ2 an order under another contract?
Yes. SPE2DR26FXUZ2 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXUZ2 competed?
The extent of competition for SPE2DR26FXUZ2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award